"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Texas Oncology - San Antonio Medical Center conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 24 clinical trials were completed, i.e. on average, 35.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 18 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology - San Antonio Medical Center" #1 sponsor was "Seagen Inc." with 8 trials, followed by "Incyte Corporation" with 6 trials sponsored, "Novartis Pharmaceuticals" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology - San Antonio Medical Center" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 4 trials as a collaborator, "GOG Foundation" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology - San Antonio Medical Center" are "Ovarian Cancer" (12 trials), "Breast Cancer" (5 trials), "Endometrial Cancer" (5 trials), "Metastatic Breast Cancer" (5 trials) and "Cancer" (3 trials). Many other conditions were trialed in "Texas Oncology - San Antonio Medical Center" in a lesser frequency.

Most popular intervention types in "Texas Oncology - San Antonio Medical Center" are "Drug" (65 trials), "Biological" (8 trials), "Other" (6 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Nivolumab" (6 trials), "Paclitaxel" (5 trials), "Rituximab" (5 trials) and "Abemaciclib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology - San Antonio Medical Center" are 53 trials for "All" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Texas Oncology - San Antonio Medical Center". undefined are not yet recruiting, 17 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Texas Oncology - San Antonio Medical Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology - San Antonio Medical Center, 15 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".